Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 33,532 shares at $78.72 ($2.6M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $2.6M MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.72 | 16,766 | $1.3M | 50.0% |
| 2 | $78.72 | 16,766 | $1.3M | 50.0% |
| Total | $78.72 avg | 33,532 | $2.6M | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |